4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000950170-24-115432
President and CEO sold 58,726 shares at an average $25.77 ($1,513,271)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd President and CEO | 2024-10-15 | Sale 10b5-1 | −10,035 | $24.31 | $243,970 | 1,467,338 | D: show line 1 in the form |
| Harris Todd President and CEO | 2024-10-16 | Sale 10b5-1 | −4,900 | $25.22 | $123,556 | 1,462,438 | D: show line 2 in the form |
| Harris Todd President and CEO | 2024-10-16 | Sale 10b5-1 | −24,475 | $26.23 | $642,062 | 1,437,963 | D: show line 3 in the form |
| Harris Todd President and CEO | 2024-10-16 | Sale 10b5-1 | −3,922 | $26.98 | $105,811 | 1,434,041 | D: show line 4 in the form |
| Harris Todd President and CEO | 2024-10-17 | Sale 10b5-1 | −15,194 | $25.84 | $392,598 | 1,418,847 | D: show line 5 in the form |
| Harris Todd President and CEO | 2024-10-17 | Sale 10b5-1 | −200 | $26.37 | $5,274 | 1,418,647 | D: show line 6 in the form |
| Open-market sales · 58,726 sh · avg $25.77 · $1,513,271 | |||||||
Loading xslF345X05/ownership.xml…